The pathogenesis of Alzheimer’s disease (AD), the most common senile dementia, is a complex process. A crucial event in AD is the aggregation of amyloid-β protein (Aβ), a cleavage product from the Amyloid Precursor Protein (APP). Aβ40, a common component in amyloid plaques found in patients, aggregates in vitro at concentrations, much higher than the one found in vivo. But in the presence of charged lipid membranes, aggregations occurs at much lower concentration in vitro compared to the membrane-free case. This can be understood due to the ability of Aβ to get electrostatically attracted to target membranes with a pronounced surface potential. This electrostatically driven process accumulates peptide at the membrane surface at concentrations high enough for aggregation while the bulk concentration still remains below threshold. Here, we elucidated the molecular nature of this Aβ-membrane process and its consequences for Aβ misfolding by Circular Dichroism Spectroscopy, Differential Scanning Calorimetry and Nuclear Magnetic Resonance Spectroscopy. First, we revealed by NMR that Aβ40 peptide does indeed interact electrostatically with membranes of negative and positive surface potential. Surprisingly, it even binds to nominal neutral membranes if these contain lipids of opposite charge. Combined NMR and CD studies also revealed that the peptide might be shielded from aggregation when incorporated into the membrane. Moreover, CD studies of Aβ40 added to charged membranes showed that both positively and negatively membranes induce aggregation albeit at different kinetics and finally that macromolecular crowding can both speed up and slow down aggregation of Aβ.

Neste trabalho estudamos por espalhamento de raios-X a baixos ângulos (SAXS) quatro diferentes sistemas de interesse biológico. Visamos investigar a auto-agregação de proteínas e de complexos proteicos que darão origem a fibras amilóides, interação proteína-proteína, simulando ambientes altamente concentrados, interação proteína-membrana simulando vesículas de matriz extracelular (MVs) de sistemas de biomineralização e interações proteína-agentes desnaturantes. No caso de formação de amilóides, investigamos a agregação do domínio GTPase da septina 6 (SEPT6G) e do complexo formado com o domínio GTPase da septina 2 (SEPT2G-SEPT6G). A temperaturas de até 15°C, tanto SEPT6G quanto SEPT2G-SEPT6G apresentam-se predominantemente diméricas em solução. Já a 25°C, o heterodímero SEPT2G-SEPT6G permanece estável enquanto agregados maiores de SEPT6G evoluem e coexistem em solução com SEPT6G-SEPT6G dimérica, sendo que a proporção de dímeros diminui com a temperatura. No estudo das MVs, mostramos que miméticos lipossomais de DPPC e DPPC:DPPS (9:1) possuem as mesmas características estruturais na ausência e presença de cálcio na solução. A interação da proteína anexina V humana (A5), envolvida em processos de biomineralização, impacta na membrana modelo induzindo a formação de nanoporos. A adição da fosfatase alcalina tecido não-específico (TNAP) não altera as propriedades estruturais do proteolipossomo na presença de A5. A ação do surfactante dodecil sulfato de sódio (SDS) a 30 mM não altera a conformação da albumina soro bovina (BSA), de maneira que é observada a formação de micelas de SDS coexistindo com a proteína livre em solução. Já a adição de 50 mM de SDS induz um desenovelamento parcial da proteína, identificado pela análise das curvas de SAXS via modelo de \"colar de pérolas\". A ação de uréia a 3 M e 8 M promove um desenovelamento parcial e total da BSA, respectivamente, com subsequente agregação de proteína dependente da temperatura (T > 30°C). A adição de 6 mM de SDS em proteínas parcialmente desenoveladas pela ação da uréia promove um desenovelamento mais acentuado. O potencial efetivo resultante da interação entre duas proteínas distintas, BSA e lisozima a concentração total de 100 mg/mL em solução, pH 7.0, foi obtido da análise de curvas de SAXS. Para isto, utilizou-se uma análise simplificada (em primeira aproximação) considerando um potencial efetivo de interação entre BSA-BSA, lisozima-lisozima e lisozima-BSA. Variamos a razão molar BSA:LISO até 1:42. No pH estudado, BSA tem uma carga residual superficial de -11e, enquanto a lisozima possui +9e. Conforme variamos a razão molar BSA:LISO, observamos dois regimes para o potencial efetivo resultante: i) até BSA:LISO 1:2, a carga efetiva do sistema é praticamente nula com um potencial resultante de caráter atrativo e ii) para razões entre BSA:LISO 1:3 a 1:42, a carga efetiva aumenta e o potencial resultante tem caráter repulsivo. Assim, lisozima e BSA coexistem sem agregar, através de um delicado balanço de forças atrativas e repulsivas no sistema. / In this work we have used small-angle x-ray scattering (SAXS) to study four systems of biological interest. We aim to investigate the self aggregation of proteins and protein complexes that would form amyloid fibers; protein/protein interaction, simulating high concentrations; protein/cell-membrane interaction, simulating extracellular matrix vesicles (MVs) from biomineralizing systems; and protein/denaturating-agents interactions. On the case of amyloid formation, we have investigated the aggregation of G-domain of septin-6 (SEPT6G) and the protein complex formed with G-domain of septin-2 (SEPT2G-SEPT6G). At temperatures lower than 15°C, both SEPT6G and SEPT2G-SEPT6G were found predominantly as dimers. At 25°C, SEPT2G-SEPT6G heterodimer is still stable while aggregates of SEPT6G grow. Both coexist in solutions of SEPT2G-SEPT6G dimers, with the percentage of dimers decreasing the higher the temperature. As for the study of MVs, we have shown that DPPC and DPPC:DPPS (9:1) liposomal mimetics have the same structural characteristics at the absence or presence of Calcium. The interaction with human annexin V protein (A5), related to biomineralization processes, affects the model membrane by the creation of nanopores. The addition of tissue-nonspecific alkaline phosphatase (TNAP) does not change the structural properties of the proteoliposome when A5 is present. The addition of SDS surfactant (30 mM) does not alters the conformation of bovine serum albumin (BSA), and we have observed the formation of SDS micelles coexisting with free protein in solution. The addition of 50 mM of SDS, on the other hand, induces the partial unraveling of the protein, as seen by the analysis of SAXS data via the pearl necklace\'\' model. The effect of adding 3M and 8M urea is, respectively, the partial and total unraveling of BSA, with ensuing aggregation of the protein dependent on the temperature (T > 30°C). The introduction of SDS 6mM promotes further unraveling in proteins that were previously partially unraveled by urea. The resulting effective potential for the interaction between BSA and lysozyme at total concentration of 100mg/ml and 7.0 pH has been obtained from the analysis of SAXS curves. In order to obtain this result we have used a simplified analysis (first order approximation) in which were considered the effective potentials for the interactions between BSA-BSA, lysozyme-lysozyme and lysozyme-BSA. We have varied the BSA:LISO molar ratio up to 1:42. At the studied pH, BSA has a surface residual charge of -11e, and lysozyme has +9e. As we changed the BSA:LISO molar ratio, we have found two regimens for the resulting effective potential: i) up to BSA:LISO 1:2, the effective charge of the system is virtually zero and the resulting potential is attractive; and ii) for BSA:LISO between 1:3 and 1:42 the effective charge increases, and the resulting potential is repulsive. Therefore, both lysozyme and BSA coexist without forming aggregates, by a delicate balance of attractive and repulsive forces.

La Maladie d’Alzheimer (MA) est un des challenges sanitaires les plus importants du XXIème siècle. En effet, elle touche 35,6 millions de personnes en 2010, et en atteindra probablement quatre fois plus en 2050.Cependant, peu d’éléments sont à ce jour connus concernant les mécanismes de toxicité de cette maladie. Il semble néanmoins acquis que l’agrégation du peptide amyloïde Aβ est l’élément déclenchant une cascade d’événements cellulaires aboutissant à trois types de lésions : les dégénérescences neurofibrillaires, les plaques amyloïdes et une atrophie corticale, révélatrice d’une importante mort neuronale.Différents modèles transgéniques d’étude de la toxicité du peptide Aβ ont été créés au cours des vingt dernières années. Cependant, aucun modèle de levure n’a encore vu le jour, alors que cet organisme est utilisé depuis de nombreuses années pour l’étude des protéines amyloïdes.J’ai donc cherché à créer ce modèle de toxicité au cours de ma thèse. L’adressage d’une protéine de fusion Aβ-GFP à la voie de sécrétion permet de rendre son expression toxique chez la levure. J’ai démontré que le trafic intracellulaire était un élément important pour la génération d’espèces toxiques. Les orthologues de PICALM, facteur de prédisposition à la MA, sont impliqués dans la toxicité, montrant une conservation des mécanismes de toxicité avec l’Homme. Les constructions semblent avoir la capacité de traverser les membranes afin d’atteindre des cibles cellulaires comme la mitochondrie.Le modèle ainsi construit nous permettra de mettre en place une étude de la relation entre la structure et la toxicité du peptide Aβ et mieux comprendre les mécanismes cellulaires régissant la MA. / Alzheimer’s Disease (AD) is one of the most important sanitary challenges of the XXIst century. Indeed, 35.6 million people are affected in 2010, and there will be probably four times more in 2050. However, little is known about the mechanisms of toxicity of this disease. Nevertheless, it seems that aggregation of the Aβ peptide is the triggering factor of a cascade of cellular events that leads to three characteristic lesions: neurofibrillary tangles, amyloid plaques and a cortical atrophy, revealing an important neuronal death. Different transgenic models for the study of the Aβ peptide toxicity have been created during the past twenty years. However, no yeast model has yet seen the light of day, whereas this organism is used for several years to study amyloid proteins.Therefore I worked to create this model during my thesis. Addressing an Aβ-GFP fusion to the secretory pathway enable this construction to become toxic in yeast. I proved intracellular pathways are important for generation of toxic species. PICALM orthologs, an AD predisposing factor, are involved in toxicity, showing conservation in the mechanisms of toxicity between yeast and man. The constructions seem to be able to cross membranes and reach cytoplasmic targets as mitochondria.Thus, this model will allow us to set a study of the relationship between structure and toxicity of the Aβ peptide and better understand the cellular mechanisms governing AD

No description available.

Small fluorescent probes are important tools when studying protein aggregates involved in different neurodegenerative diseases, such as Alzheimer’s disease. Luminescent conjugated oligothiophenes have been developed and shown to be excellent ligands when studying morphology among amyloids, due to their conjugated thiophene backbone that provides them with unique photophysical properties. This kind of probes are being developed successively to enhance the specificity of their biological targets. In this project, luminescent conjugated oligothiophenes functionalized with amino acids, so called proteophenes, have been synthesized to investigate their optical properties. Since amino acids are chiral molecules, the possibility of induced chirality to the thiophene backbone was examined, as well as the proteophenes ability to work as amyloidospecific ligands for the study of protein aggregates. The synthesis of four different proteophenes are presented in this report, along with analysis results of their photophysical properties.

Ces travaux de thèse concernent la synthèse et l’étude des propriétés optiques de fluorophores organiques appliqués à la détection de deux biomarqueurs de la maladie d’Alzheimer : la protéine kinase C (PKC) et les fibrilles de peptides amyloïdes Aβ42. La détection de la PKC est réalisée à l’aide de dyades comprenant un émetteur de type boradiazaindacène (BODIPY) relié de manière covalente à un inhibiteur de cette enzyme. Ces composés obtenus via une synthèse multi-étape présentent des coefficients d’absorption molaires et des rendements quantiques de fluorescence en solution importants. Ces sondes ont ensuite été utilisées en cytométrie de flux par la société Amoneta Diagnostics afin de détecter la PKC en surface des globules rouges et d’évaluer le potentiel de ces sondes dans le diagnostic de la maladie d’Alzheimer par test sanguin. Pour la détection des fibrilles de peptides amyloïdes, deux séries de fluorophores de la famille des 2-(2’-hydroxyphényl)-benzoxazoles ont été étudiées. Ces molécules présentent un phénomène de transfert de proton intramoléculaire à l’état excité (ESIPT) qui leur confère des propriétés optiques remarquables, telles que d’importants déplacements de Stokes et une émission duale. Enfin, un test de détection in vitro a été mis au point. Une interaction entre ces fluorophores et les fibrilles amyloïdes a pu être observée permettant la détection de ces peptides en solution. / This research concerns the synthesis and photophysical studies of organic fluorescent probes applied to the detection of two Alzheimer’s disease biomarkers: the protein kinase C and fibrils of amyloid Aβ42 peptides. PKC detection is achieved by dyads composed of boradiazaindacene dye (BODIPY) covalently linked to an inhibitor of this enzyme. These compounds afforded by a multistep synthesis display high molar absorption coefficients and quantum yields in solution. These probes were then used in flow cytometry by Amoneta Diagnostics to detect PKC on the surface of red blood cells in order to asses the potential of these molecules for the diagnostic of Alzheimer’s disease by blood test. Two series of fluorophores from the 2-(2’-hydroxyphenyl)-benzazole family have been studied for the detection of amyloid fibrils. These molecules display an excited state intramolecular proton transfer (ESIPT) phenomenon which confer them remarkable optical properties such as important Stokes shifts and dual emission. Finally, an in vitro detection test has been developed. Interactions between these dyes and amyloid fibrils has been observed, allowing the detection of these peptides in solution.

Alzheimer's disease (AD) is a large and growing problem and while we today lack a full understanding of this disease, we know that the protein tau and the amyloid fibrils it forms play a central role in its development. We also know that these fibrils can have different morphologies in different diseases and that fibrils produced in vitro not necessarily adopt any of the morphologies found in patients. This means there is a need for more pathologically relevant fibrils in vitro to be able to understand this disease better. One approach to satisfy this need is to use fibrils found in patients as seeds and thus transfer their morphology to recombinantly purified protein. To facilitate this process this study has attempted to develop a way to differentiate between different fibril morphologies using a FRET based system. This involves fluorescent fusion proteins (tau-EXFPs) and fluorescent amyloid probes as well as seeding experiments with pseudo wild type tau (PWT) and tau with the P301L mutation. Greater differences in terms of fibrillation rates and ThT fluorescence between PWT and P301L was shown than previously reported between WT and P301L. They were also shown to differ in fibril morphology in TEM. The ThT fluorescence intensity was to a certain degree transferable from PWT to P301L by seeding. Furthermore, this study confirms that the tau-EXFP fusion protein can be incorporated into amyloid fibrils and strongly suggests that a FRET effect between EXFP and BTD14 (as well as X34 and ThT) can be achieved. It also demonstrates differences in FRET efficiency between PWT and P301L fibrils using FLIM. These results indicate that a FRET based approach could be a useful method to discern different fibril morphologies from each other, but further measurements and optimization are needed before this method could be reliably applied. The fusion proteins could also be used to investigate tau spreading in vivo, e.g. in D. melanogaster. To find suitable FRET partners to the fusion proteins, a ligand screen was conducted. This could be used as an alternative to the FRET method. With the right selection of fluorescent amyloid probes, a unique fingerprint for each fibril morphology could maybe be generated and fulfill the same intended function as the FRET method.

Il a été observé que l’altération des fonctions des granules de stress, entités cytoplasmiques non-membranaires composées d’ARN et de protéines liant l’ARN (RBPs), peut conduire au développement de maladies telles que la sclérose latérale amyotrophique, la démence fronto-temporale, la myopathie à inclusions et la maladie de Paget des os. Ces pathologies sont caractérisées par un dépôt cytoplasmique d’inclusions solides enrichies en RBPs et comprenant des fibrilles. Une connexion génétique a été suggérée entre la persistance des granules de stress et l’accumulation de ces inclusions pathologiques dans le cytoplasme des patients. Dans mon manuscrit de thèse, il est mis en évidence le fait que la protéine hnRNPA1, dont les mutations entrainent les maladies mentionnées plus haut, subit une séparation de phases entre deux liquides connue également sous l’appellation « Séparation de Phases Liquide-Liquide » (LLPS) dans des gouttelettes enrichies en protéines. Bien que le domaine composé d’une séquence à faible complexité (Low Complexity sequence Domains ou LCD) soit suffisant pour obtenir cette séparation de phases, les domaines de liaison à l’ARN y contribuent également en présence d’ARN. Cela a permis d’envisager l’existence de plusieurs mécanismes intervenant dans la régulation de l’assemblage de ces granules. Un autre résultat a mis en exergue le fait que la formation de fibrilles n’est pas une obligation pour permettre la séparation de phases mais que les gouttelettes, enrichies en protéines, entrainent, par ailleurs, une augmentation de la formation de ces fibrilles. La séparation de phases liquide-liquide induite par le domaine composé d’une séquence à faible complexité semble contribuer à l’assemblage des granules de stress et à leurs propriétés liquides. Finalement, cette étude propose d’établir une réelle corrélation entre la formation des granules de stress qui deviennent persistants et l’accumulation d’inclusions pathologiques dans le cytoplasme des patients. / Stress granules are membrane-less organelles composed of RNA-binding proteins (RBPs) and RNA. Functional impairment of stress granules has been implicated in amyotrophic lateral sclerosis, inclusion body myopathy, Paget’s disease of bone and frontotemporal dementia; these diseases are characterized by solid, fibrillar, cytoplasmic inclusions that are rich in RNA binding proteins (RBPs). Genetic evidence suggests a link between persistent stress granules and the accumulation of pathological inclusions. In this thesis manuscript, I demonstrate that the disease-related RBP hnRNPA1 undergoes liquid-liquid phase separation (LLPS) into protein-rich droplets mediated by a low complexity sequence domain (LCD). While the LCD of hnRNPA1 is sufficient to mediate LLPS, the folded RNA recognition motifs contribute to LLPS in the presence of RNA, potentially giving rise to several mechanisms for regulating assembly of stress granules. Importantly, while not required for LLPS, fibrillization is enhanced in protein-rich droplets. I suggest that LCD-mediated LLPS contributes to the assembly of stress granules and their liquid properties, and provides a mechanistic link between persistent stress granules and fibrillar protein pathology in disease.

La maladie d'Alzheimer, maladie neurodégénérative la plus courante, est la cause de50% des cas de démence. La maladie d’Alzheimer est provoquée par l'agrégation d'unamyloïde, le peptide Aβ1-42, dans le cerveau des patients.De nombreuses études relient la toxicité des amyloïdes à l'existence de diversesstructures intermédiaires survenant avant la formation des fibres et / ou leur interactionspécifique avec les membranes.Dans cette étude, nous nous sommes centrés sur l'interaction entre des modèlesmembranaires et le peptide Aβ1-42 (WT et des mutants plus ou moins toxiques) évaluée parplusieurs techniques biophysiques (ellipsométrie, PM-IRRAS, fluorescence de la ThT, fuitede calcéine, PWR, cryo-MET). Nous avons tout d'abord étudié l’interaction avec des modèlesde membrane simples (100% DOPG ou 100% DOPC). Nous avons établi que la force motricede l'interaction entre tous les peptides et la membrane n’est pas régie par des interactionsélectrostatiques, mais est favorisée en présence des têtes polaires PG qui peuvent interagiravec le peptide par l'intermédiaire de liaisons hydrogènes. Nous avons démontré quel'oligomère le plus toxique induit des dommages sur les membranes de PG, ce qui diminue laformation de fibres.Une nouvelle composition lipidique constituée de GM1, cholestérol, sphingomyélineet POPC a été choisie pour mimer les membranes neuronales. Des techniques innovantes : laspectroscopie infrarouge à l'échelle nanométrique et l’AFM haute-vitesse ont été utilisées,respectivement, pour accéder à la morphologie et la structure secondaire des peptides enprésence de membranes et observer la dynamique de cette interaction. Les résultats obtenusmontrent que les gangliosides GM1 et le cholestérol jouent un rôle central dans l'interactiond’Aβ avec les membranes. Nous avons été en mesure de proposer un modèle du mécanismed'interaction : Aβ1-42 s’accumule sur les domaines de GM1 présents dans la membrane via desliaisons hydrogène, puis s’insère dans la membrane par les domaines enrichis en cholestérol.Le cholestérol et les gangliosides sont nécessaires pour l'interaction d’Aβ1-42 avec lamembrane.Afin de suivre la cinétique d'agrégation d’Aβ et de comprendre ses différents étatsd'agrégation par spectroscopie infrarouge, l’élaboration d’une cellule microfluidique adaptée aété entreprise. / Alzheimer’s disease is the most common neurodegenerative disease, leading to 50% ofdementia cases, caused by the aggregation of an amyloid, the Aβ1-42 peptide in patients brain.Many studies link the toxicity of amyloids, as A1-42 involved in Alzheimer disease, tothe existence of various intermediate structures prior to fiber formation and /or their specificinteraction with membranes.In this study we focused on the interaction between membrane models and A1-42peptides and variants more or less toxic with several biophysical techniques (ellipsometry,PM-IRRAS, ThT fluorescence, calceine leakage, PWR, cryo-TEM). First, with simplemembrane models (pure DOPG or pure DOPC), we established that the driving force for theinteraction between all the peptides and membrane is not governed by electrostatic interactionbut is favored in presence of PG headgroups that may interact with peptide via hydrogenbonding. We demonstrated that the most toxic oligomer induces PG membrane damage,decreasing the formation of fibers.New lipid composition GM1, cholesterol, sphingomyelin and POPC has been chosento mimic neuronal membranes. Innovative techniques: as nanoscale infrared spectroscopy andhigh-speed AFM were used to assess to the morphology and the secondary structure of thepeptides in presence of membrane and to observe the dynamic of this interaction,respectively. The results obtained show that the gangliosides GM1 and the cholesterol play acentral role in the interaction of Aβ with membranes. We were able to propose a model of theinteraction mechanism: Aβ1-42 firstly accumulates on the GM1 domains present in themembrane via hydrogen bonding and then inserts the membrane in the cholesterol enricheddomains. Cholesterol and gangliosides are required for the interaction of Aβ1-42 withmembrane.In order to follow the kinetic of Aβ agregation and understand its different agregationstates with infrared spectroscopy, a microfluidic cell fabrication has been investigated.

Alzheimer’s Disease, also called AD, is a horrible, degenerative brain disease that more than 35 million people over the world have. Today, there is no cure for this disease, only treatments that are temporarily relieving the symptoms. The two proteins that is thought to be the main cause of AD is amyloid β (Aβ) and tau. Previously, people have tried studying Aβ in vivo using green fluorescent protein fusion together with Aβ. However, this is difficult since the aggregation of Aβ will lead to loss of fluorescence. This study aimed to crystallize the fusion protein mNG-A β1-42 and to investigate its properties as a molecular fluorescent Aβ-amyloid specific probe. Dynamic light scattering (DLS) was used to confirm that the majority of the protein was not in the form of soluble aggregates. The DLS experiments were followed by several rounds of crystallization trials. Initial screening and the subsequent narrowing down of potential conditions where mNG-Aβ1-42 could form crystals. Several staining experiments were conducted as well, including staining brain tissue from mouse with both Swedish and Arctic mutation, from human patients with sporadic AD and from human patients with AD with the Arctic mutation. The DLS experiments showed that the protein used in the crystallization experiments mostly consisted of molecular particles of the same radius. However, there was clear evidence of some larger species present that could have been a potential problem for crystallization. Crystallization experiments suggested that PEG 8000 was the most promising precipitant amongst other conditions identified for crystallization of mNG-Aβ1-42. However, the study was ultimately unsuccessful in developing crystals of sufficient high quality for diffraction studies to commence. The staining experiments demonstrated that mNG-Aβ1-42 could bind both by itself and with another amyloid probe, Congo red, and with antibodies in brain tissue from mouse with both Swedish and Arctic mutation, from human patients with sporadic AD and from human patients with AD with the Arctic mutation. In conclusion, several characteristics of mNG-Aβ1-42 were revealed in this study.